Danuta M. Skowronski

14.6k total citations · 1 hit paper
168 papers, 7.7k citations indexed

About

Danuta M. Skowronski is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Danuta M. Skowronski has authored 168 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Epidemiology, 48 papers in Infectious Diseases and 33 papers in Modeling and Simulation. Recurrent topics in Danuta M. Skowronski's work include Influenza Virus Research Studies (107 papers), Respiratory viral infections research (74 papers) and COVID-19 epidemiological studies (33 papers). Danuta M. Skowronski is often cited by papers focused on Influenza Virus Research Studies (107 papers), Respiratory viral infections research (74 papers) and COVID-19 epidemiological studies (33 papers). Danuta M. Skowronski collaborates with scholars based in Canada, United States and Ivory Coast. Danuta M. Skowronski's co-authors include Gaston De Serres, Mel Krajden, Robert C. Brunham, Martin Petric, Suzana Sabaiduc, Nathalie Bastien, Hugues Charest, Babak Pourbohloul, Lauren Ancel Meyers and James A. Dickinson and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Danuta M. Skowronski

164 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of Severe Acute Respiratory Syndrome in Canada

2003 867 citations Bonnie Henry, Danuta M. Skowronski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danuta M. Skowronski Canada	44	5.6k	2.7k	1.3k	1.1k	841	168	7.7k
Gaston De Serres Canada	56	8.2k 1.5×	3.1k 1.1×	922 0.7×	1.8k 1.6×	699 0.8×	299	10.5k
Karen R. Broder United States	38	6.1k 1.1×	2.3k 0.8×	447 0.4×	2.7k 2.5×	177 0.2×	91	8.5k
Jonathan B. Gubbay Canada	37	3.8k 0.7×	3.4k 1.3×	601 0.5×	660 0.6×	359 0.4×	172	6.9k
Paul Gargiullo United States	33	3.7k 0.7×	1.9k 0.7×	528 0.4×	782 0.7×	441 0.5×	73	5.9k
Karl G. Nicholson United Kingdom	44	5.7k 1.0×	2.0k 0.7×	470 0.4×	504 0.5×	751 0.9×	112	7.2k
Natasha S. Crowcroft Canada	43	4.8k 0.9×	2.8k 1.0×	603 0.5×	1.8k 1.7×	122 0.1×	262	8.2k
Adam Meijer Netherlands	44	5.4k 1.0×	2.4k 0.9×	764 0.6×	163 0.1×	1.0k 1.2×	201	7.3k
Paul Fine United Kingdom	57	5.9k 1.1×	7.6k 2.8×	1.1k 0.8×	1.4k 1.2×	320 0.4×	195	12.6k
Ismael R. Ortega‐Sanchez United States	27	4.3k 0.8×	1.1k 0.4×	515 0.4×	1.5k 1.4×	166 0.2×	62	5.5k
John J. Treanor United States	51	5.9k 1.1×	3.0k 1.1×	327 0.3×	429 0.4×	822 1.0×	126	8.2k

Countries citing papers authored by Danuta M. Skowronski

Since Specialization

Citations

This map shows the geographic impact of Danuta M. Skowronski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danuta M. Skowronski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danuta M. Skowronski more than expected).

Fields of papers citing papers by Danuta M. Skowronski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danuta M. Skowronski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danuta M. Skowronski. The network helps show where Danuta M. Skowronski may publish in the future.

Co-authorship network of co-authors of Danuta M. Skowronski

This figure shows the co-authorship network connecting the top 25 collaborators of Danuta M. Skowronski. A scholar is included among the top collaborators of Danuta M. Skowronski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danuta M. Skowronski. Danuta M. Skowronski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carazo, Sara, Danuta M. Skowronski, Katia Giguère, et al.. (2025). Effectiveness of COVID-19 Vaccination and Prior Infections to Reduce Long COVID Risk During the Pre-Omicron and Omicron Periods. Clinical Infectious Diseases. 82(3). e436–e445.

Brousseau, Nicholas, Sara Carazo, Geneviève Cadieux, et al.. (2023). Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk. Clinical Infectious Diseases. 78(2). 461–469. 14 indexed citations

Skowronski, Danuta M., Michael A. Irvine, Shin Hye Kim, et al.. (2023). Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada. Canadian Medical Association Journal. 195(42). E1427–E1439. 7 indexed citations

Francis, Magen E., Rachelle Buchanan, Kerry J. Lavender, et al.. (2023). Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2. Nature Communications. 14(1). 5990–5990. 2 indexed citations

Carazo, Sara, Danuta M. Skowronski, Robert Laforce, et al.. (2022). Physical, Psychological, and Cognitive Profile of Post-COVID Conditions in Healthcare Workers, Quebec, Canada. Open Forum Infectious Diseases. 9(8). ofac386–ofac386. 15 indexed citations

Skowronski, Danuta M., Solmaz Setayeshgar, Macy Zou, et al.. (2022). Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada. The Journal of Infectious Diseases. 226(3). 485–496. 7 indexed citations

Carazo, Sara, Danuta M. Skowronski, Marc Brisson, et al.. (2022). Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. The Lancet Infectious Diseases. 23(1). 45–55. 55 indexed citations

Skowronski, Danuta M., Michael A. Irvine, Shinhye Kim, et al.. (2022). Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada. Canadian Medical Association Journal. 194(47). E1599–E1609. 38 indexed citations

Skowronski, Danuta M., Solmaz Setayeshgar, Macy Zou, et al.. (2021). Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada. Clinical Infectious Diseases. 74(7). 1158–1165. 35 indexed citations

10.

Carazo, Sara, Denis Talbot, Nicole Boulianne, et al.. (2021). Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada. Clinical Infectious Diseases. 75(1). e805–e813. 22 indexed citations

11.

Skowronski, Danuta M., et al.. (2018). Increase in Hospital Admissions for Severe Influenza A/B among Travelers on Cruise Ships to Alaska, 2015. Emerging infectious diseases. 24(3). 566–568. 3 indexed citations

12.

Carazo, Sara, Gaston De Serres, Alexandre Bureau, & Danuta M. Skowronski. (2017). Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose. Clinical Infectious Diseases. 65(7). 1094–1102. 22 indexed citations

13.

Aoki, Fred Y., Upton Allen, H Grant Stiver, et al.. (2015). Guidance for Practitioners on the Use of Antiviral Drugs to Control Influenza Outbreaks in Long‐Term Care Facilities in Canada, 2014‐2015 Season. Canadian Journal of Infectious Diseases and Medical Microbiology. 26(1). e1–4. 6 indexed citations

14.

Janjua, Naveed Z., Danuta M. Skowronski, Gaston De Serres, et al.. (2012). Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants. The Journal of Infectious Diseases. 205(12). 1858–1868. 48 indexed citations

15.

Baz, Mariana, Jesse Papenburg, Marie‐Ève Hamelin, et al.. (2012). Seroconversion to Seasonal Influenza Viruses after A(H1N1)pdm09 Virus Infection, Quebec, Canada. Emerging infectious diseases. 18(7). 1132–4. 5 indexed citations

16.

Salway, Travis, Danuta M. Skowronski, Brett Hiebert, et al.. (2011). Influenza Vaccine Effectiveness in the Elderly Based on Administrative Databases: Change in Immunization Habit as a Marker for Bias. SSRN Electronic Journal. 2 indexed citations

17.

Serres, Gaston De, Frédéric Dallaire, Mathieu Côté, & Danuta M. Skowronski. (2008). Bat Rabies in the United States and Canada from 1950 through 2007: Human Cases With and Without Bat Contact. Clinical Infectious Diseases. 46(9). 1329–1337. 54 indexed citations

18.

Toth, Ellen L., Sandrine Ménard, J.F. Grenier, et al.. (2005). Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons. Vaccine. 23(28). 3726–3732. 13 indexed citations

19.

Tan, Tina Q., Scott A. Halperin, James D. Cherry, et al.. (2005). Pertussis Immunization in the Global Pertussis Initiative North American Region. The Pediatric Infectious Disease Journal. 24(5). S83–S86. 35 indexed citations

20.

Skowronski, Danuta M.. (2005). Survey for Serious Adverse Events (SAEs) following Immunization with the 4 th Dose of a Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus and Haemophilus influenzae Type b Combination Vaccine (DTaP-IPV//PRP-T, Pentacel™) in British Columbia (BC), Canada. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact